Skip to main content
. 2018 Feb 22;29(4):1336–1343. doi: 10.1681/ASN.2017080870

Figure 3.

Figure 3.

Study results demonstrate that ClearGuard caps are superior to Tego+Curos for reducing bloodstream infection across all nine analyses. Summary of IRRs (dots) and 95% confidence intervals (whiskers), ClearGuard facilities versus Tego+Curos facilities, for (A) primary analysis and (B–I) exploratory sensitivity analyses. Estimates<1 favor ClearGuard.